Oral mucositis: Review of pathogenesis, diagnosis, prevention, and management

General Dentistry

Volumn 55, Issue 4, 2007, Pages 335-344

  Napenas, Joel J ^a   Shetty, Kishore V ^b   Streckfus, Charles F ^b  

^a CAROLINAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

HUMAN; MUCOSA INFLAMMATION; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; REVIEW; SKULL IRRADIATION; STOMATITIS;

ANTINEOPLASTIC AGENTS; CRANIAL IRRADIATION; HUMANS; MUCOSITIS; PALLIATIVE CARE; STOMATITIS;

EID: 34547312852     PISSN: 03636771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Ruescher TJ, Sodeifi A, Scrivani SJ, Kaban LB, Sonis ST. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 1998;82:2275-2281.
2. Epstein JB, Schubert MM. Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management. Oncology 2003;17:1767-1779.
3. Bergmann OJ. Oral infections and septicemia in immunocompromised patients with hematologie malignancies. J Clin Microbiol 1988;26:2105-2109.
4. Laine PO, Lindqvist JC, Pyrhonen SO, Strand-Pettinen IM, Teerenhovi LM, Meurman JH. Oral infection as a reason for febrile episodes in lymphoma patients receiving cytostatic drugs. Eur J Cancer B Oral Oncol 1992;286:103-107.
5. Elting LS, Bodey GP, Keefe BH. Septicema and shock syndrome due to viridans streptococci: A case-control study of predisposing factors. Clin Infect Dis 1992;14:1201-1207.
6. Spijkervet FK, van Saene HK, Panders AK, Vermey A, Mehta DM. Scoring irradiation mucositis in head and neck patients. J Oral Pathol Med 1989;18:167-171.
7. Rowat JS, Squier CA. Rates of epithelial cell proliferation in the oral mucosa and skin of the tamarin monkey (Saguinus fuscicollty. J Dent Res 1986;65:1326-1331.
8. Dreizen S. Oral complications of cancer therapies. Description and incidence of oral complications. NCI Monogr 1990;9:11-15.
9. Raber-Durlacher JE, Weijl NI, Abu Saris M, de Koning B, Zwinderman AH, Osanto S. Oral mucositis in patients treated with chemotherapy for solid tumors: A retrospective analysis of 150 cases. Support Care Cancer 2000;8:366-371.
10. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2003;98:1531-1539.
11. Peterson DE. New strategies for management of oral mucositis in cancer patients. J Support Oncol 2006;4:9-13.
12. Peterson DE. Pretreatment strategies for infection prevention in chemotherapy patients. NCI Monogr 1990;9:61-71.
13. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L, Zilberberg MD. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol 2003;66:253-262.
14. Donnelly JP, Muus P, Schattenberg A, De Witte T, Horrevorts A, DePauw BE. A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients. Bone Marrow Transplant 1992;9:409-413.
15. Rose-Ped AM, Bellm LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ. Complications of radiation therapy for head and neck cancers. The patient's perspective. Cancer Nurs 2002;25:461-467.
16. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer 2000;8:33-39.
17. Epstein JB, Klasser GD. Emerging approaches for prophylaxis and management of oropharyngeal mucositis in cancer therapy. Expert Opin Emerg Drugs 2006;11:353-373.
18. Lockhart PB, Sonis ST. Alterations in the oral mucosa caused by chemotherapeutic agents. A histologic study. J Dermatol Surg Oncol 1981;7:1019-1025.
19. Sonis ST, Peterson RL, Edwards LJ, Lucey CA, Wang L, Mason L, Login G, Ymamkawa M, Moses G, Bouchard P, Hayes LL, Bedrosian C, Dorner AJ. Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol 2000;36:373-381.
20. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, RaberDurlacher J, Donnelly JP, Rubenstein EB; Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004;100 (9 Suppl):1995-2025.
21. Ulrich CM, Yasui Y, Storb R, Schubert MM, Wagner JL, Bigler J, Ariail KS, Keener CL, Li S, Liu H, Farin FM, Potter JD. Pharmacogenetics of methotrexate: Toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood 2001;98:231-234.
22. Dorr W, Spekl K, Martin M. Radiation-induced oral mucositis in mice: Strain differences. Cell Prolif 2002;35:60-67.
23. Bostrom B, Weisdorf D. Mucositis and alphastreptococcal sepsis in bone marrow transplant recipients. Lancet 1984;1:1120-1121.
24. Cohen J, Donnelly JP, Worsley AM, Catovsky D, Goldman JM, Galton DA. Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet 1983;2:1452-1454.
25. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-214.
26. Trotti A, Byhardt R, Stetz J, Gwede C, Com B, Fu K, Gunderson L, McCormick B, Morrisintegral M, Rich T, Shipley W, Curran W. Common toxicity criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:13-47.
27. Sonis ST. New trends in the management of oral mucositis. Available at: http://www.professional.cancerconsultants.com/conferencecoverage.aspx?id=33973. Accessed September 2006.
28. Clarkson JE, Worthington HV, Eden OB. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 2006;(2): CD000978.
29. Clarkson JE, Worthington HV, Eden OB. Prevention of oral mucositis or oral candidiasis for patients with cancer receiving chemotherapy (excluding head and neck cancer). Cochrane Database Syst Rev 2003;3:CD000978.
30. Donnelly JP, Bellm LA, Epstein JB, Sonis ST, Symonds RP. Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect Dis 2003;3:405-412.
31. Stokman MA, Spijkervet FK, Boezen HM, Scheuten JP, Roodenburg JL, de Vries EG. Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: Results of meta-analyses. J Dent Res 2006;85:690-700.
32. Scully C, Epstein J, Sonis S. Oral mucositis: A challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 1: Pathogenesis and prophylaxis of mucositis. Head Neck 2003;25:1057-1070.
33. Scully C, Epstein J, Sonis S. Oral mucositis: A challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: Diagnosis and management of mucositis. Head Neck 2004;26:77-84.
34. Greenberg MS, Cohen SG, McKitrick JC, Cassileth PA. The oral flora as a source of septicemia in patients with acute leukemia. Oral Surg Oral Med Oral Pathol 1982;53:32-36.
35. Oral complications of cancer therapies: Diagnosis, prevention and treatment. National Institutes of Health. Conn Med 1989;53:595-601.
36. Borowski B, Benhamou E, Pico JL, Laplanche A, Margainaud JP, Hayat M. Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: A randomised controlled trial comparing two protocols of dental care. Eur J Cancer B Oral Oncol 1994;308:93-97.
37. Shieh SH, Wang ST, Tsai ST, Tseng CC. Mouth care for nasopharyngeal cancer patients undergoing radiotherapy. Oral Oncol 1997;33:36-41.
38. Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM, Sorensen JM, Gainey DK, Mailliard JA, Gusa NL, et al. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 1991;9:449-452.
39. Casdnu S, Fedeli A, Fedeli SL, Catalano G. Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis. Eur J Cancer B Oral Oncol 1994;30(B):234-236.
40. Adamietz IA, Rahn R, Bottcher HD, Schafer V, Reimer K, Fleischer W. Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy. Support Care Cancer 1998;6:373-377.
41. Rahn R, Adamietz IA, Boettcher HD, Schaefer V, Reimer K, Fleischer W. Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy. Dermatology 1997;195 Suppl 2:57-61.
42. Bondi E, Baroni C, Prete A, Gatti M, Carrassi A, Lodi G, Porter SR. Local antimicrobial therapy of oral mucositis in paediatric patients undergoing bone marrow transplantation. Oral Oncol 1997;33:322-326.
43. Okuno SH, Foote RL, Loprinzi CL, Gulavita S, Sloan JA, Earle J, Novotny PJ, Burk M, Frank AR. A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis. Cancer 1997;79:2193-2199.
44. Kim JH, Chu FC, Lakshmi V, Houde R. Benzydamine HCl, a new agent for the treatment of radiation mucositis of the oropharynx. Am J Clin Oncol 1986;9:132-134.
45. Prada A, Chiesa F. Effects of benzydamine on the oral mucositis during antineoplastic radiotherapy and/or intra-arterial chemotherapy. Int J Tissue React 1987;9:115-119.
46. Epstein JB, Stevenson-Moore P, Jackson S, Mohamed JH, Spinelli JJ. Prevention of oral mucositis in radiation therapy: A controlled study with benzydamine hydrochloride rinse. Int J Radiat Oncol Biol Phys 1989,16:1571-1575.
47. Epstein JB, Silverman S Jr, Paggiarino DA, Crockett S, Schubert MM, Senzer NN, Lockhart PB, Gallagher MJ, Peterson DE, Leveque FG. Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: Results from a multi-center, randomized, double-blind, placebocontrolled clinical trial, Cancer 2001;92:875-885.
48. Samaranayake LP, Robertson AG, MacFarlane TW, Hunter IP, MacFarlane G, Soutar DS, Ferguson MM, The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation, Clin Radiol 1988;39:291-294.
49. Pillsbury HC 3rd, Webster WP, Rosenman J. Prostaglandin inhibitor and radiotherapy in advanced head and neck cancers, Arch Otolaryn gol Head Neck Surg 1986;112:552-553.
50. 2 for prophylaxis of oral mucositis following BMT, Bone Marrow Transplant 1993;11:379-382.
51. 1 analog, misoprostol: A placebo controlled double blind clinical trial. Adv Exp Med Biol 1997;400B:811-818.
52. Foncuberta MC, Cagnoni PJ, Brandts CH, Mandanas R, Fields K, Derigs HG, Reed E, Sonis ST Fay J, LeVeque F, Pouillart P, Schrezenmeier H, Emmons R, Thiel E; Investigators in TGF-beta3/OM Study Protocols 203/205, Topical transforming growth factor-beta3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors, J Immunother 2001;24:384-388.
53. Wymenga AN, van der Graaf WT, Hofstra LS, Spijkervet FK, Timens W, Timmer-Bosscha H, Sluiter WJ, van Buuren AH, Mulder NH, de Vries EG. Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis. Clin Cancer Res 1999;5:1363-1368.
54. Meropol NJ, Somer RA, Gutheil J, Pelley RJ, Modiano MR, Rowinsky EK, Rothenberg ML, Redding SW, Serdar CM, Yao B, Heard R, Rosen LS, Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: Potential role as mucosal protectant. J Clin Oncol 2003;21:1452-1458.
55. Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T, Shea T, Yanovich S, Hansen K, Noga S, McCarty J, LeMaistre CF, Sung EC, Blazar BR, Elhardt D, Chen MG, Emmanouilides C. Palifermin for oral mucositis after intensive therapy for hematologic cancers, N Engl J Med 2004;351:2590-2598.
56. Loprinzi CL, Ghosh C, Camoriano J, Sloan J, Steen PD, Michalak JC, Schaefer PL, Novotny PJ, Gerstner JB, White DF, Hatfield AK, Quella SK. Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil based chemotherapy, J Clin Oncol 1997;3:1235-1238.
57. Altai M, Huguet F, Rubie H, Charlet JP, Schlaifei D, Huynh A, Laurent G, Pris J, Prevention of regimen-related toxidties after bone marrow transplantation by pentoxifylline: A prospective, randomized trial. Blood 1993;82:732-736.
58. Verdi CJ, Garewal HS, Koenig LM, Vaughn B, Burkhead T, A double-blind, randomized, placebo-controlled, crossover trial of pentoxifylline for the prevention of chemotherapy-induced oral mucositis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;80:36-42.
59. Jensen SB, Pedersen AM, Reibel J, Nauntofte B, Xerostomia and hypofunction of the salivary glands in cancer therapy, Support Care Cancel 2003;11:207-225.
60. Awidi A, Homsi U, Kakail RI, Mubarak A, Hassan A, Kelta M, Martinez P, Sulaiti S, AI Qady A, Jamhoury A, Daniel M, Charles C, Ambrose A, El-Aloosy AS, Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer. Eur J Cancer 2001;37:2010-2014.
61. Oberbaum M, Yaniv I, Ben-Gal Y, Stein J, Ben-Zvi N, Freedman LS, Branski D. A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation. Cancer 2001;92:684-690.
62. Biswal BM, Zakaria A, Ahmad MM. Topical application of honey in the management of radiation mucositis. A preliminary study. Support Care Cancer 2003;11:242-248.
63. Huang EY, Leung SW, Wang CJ, Chen HC, Sun LM, Fang FM, Yeh SA, Hsu HC, Hsiung CY, Oral glutamine to alleviate radiation-induced oral mucositis: A pilot randomized trial. Int J Radiat Oral Biol Phys 2000;46:535-539.
64. Su CK, Mehta V, Ravikumar L, Shah R, Pinto H, Halpern J, Koong A, Goffinet D, Le QT. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms, Int J Radiat Oncol Biol Phys 2004;60:171-177.
65. Fidler P, Loprinzi CL, O'Fallon JR, Leiten JM, Lee JK, Hayes DL, Novotny P, Clemens-Schutjer D, Bartel J, Michalak JC. Prospective evaluation of chamomile mouthwash for prevention of 5-FU-induced oral mucositis, Cancer 1996;77:522-525.
66. Barasch A, Elad S, Altman A, Damtato K, Epstein J. Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. Support Care Cancer 2006;14:528-532.
67. Wilkes JD. Prevention and treatment of oral mucositis following cancer chemotherapy, Semin Oncol 1998;25:538-551.
68. Shaiova L, Lapin J, Manco LS, Shasha D, Hu K, Harrison L, Portenoy RK. Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC: ACTIQ) in patients with radiation-induced oral mucositis, Support Care Cancer 2004;12:268-273.
69. Carr DB, Goudas LC, Balk EM, Bloch R, Ioannidis JP, Lau J. Evidence report on the treatment of pain in cancer patients, J Natl Cancer Inst Monogr 2004;32:23-31.
70. Belazi M, Velegraki A, Koussidou-Eremondi T, Andreadis D, Hini S, Arsenis G, Eliopoulou C, Destouni E, Antoniades D, Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment. Oral Microbiol Immunol 2004;19:347-351.